Brief: Processa Pharmaceuticals Provides Product Pipeline And Financial Update

Processa Pharmaceuticals

28/08/2024 13:04

Aug 28 (Reuters) - Processa Pharmaceuticals Inc
 PCSA.O :
    * PROCESSA PHARMACEUTICALS PROVIDES PRODUCT PIPELINE AND
FINANCIAL
UPDATE
    * PROCESSA PHARMACEUTICALS : NGC-CAP PHASE 1B TRIAL
DEMONSTRATED A
FAVORABLE SAFETY PROFILE WITH PRELIMINARY ANTI-TUMOR ACTIVITY
    * PROCESSA PHARMACEUTICALS : PHASE 2 TRIAL WITH NGC-CAP IN
BREAST
CANCER UNDERWAY

Source text for Eikon:  ID:nGNX3nYxKK 
Further company coverage:  PCSA.O 

 ((Reuters.Briefs@thomsonreuters.com;))